US 7189393
Recombinant anti-tumor RNAse
granted A61KA61K38/00A61K47/6815
Quick answer
US patent 7189393 (Recombinant anti-tumor RNAse) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61K47/6815